Literature DB >> 15619537

Age-related ultrastructural changes in hypocretinergic terminals in the brainstem and spinal cord of cats.

Jian-Hua Zhang1, Sharon Sampogna, Francisco R Morales, Michael H Chase.   

Abstract

In a previous study, we noted the presence of enlarged "spot-like" structures that are immunoreactive to hypocretin in specific regions of brainstem of aged cats; similar structures were not seen in the same regions of adult cats. In the present study, electron microscopy was combined with hypocretin immunohistochemistry to examine the ultrastructure of these enlarged "spot-like" structures, which were found to consist of enlarged axonal terminals. The terminals were comprised of a large pale core with a dark peripheral rim. Many granules were present within the core; most of these granular structures were not immunostained. On the other hand, the rim contained a high density of hypocretin immunoreactivity; in this peripheral region, large dense-core vesicles and small synaptic vesicles without dense cores were observed. In addition, mitochondria in the peripheral rim region exhibited high electron density, which is indicative of the presence of age-related degenerative changes. Synaptic contacts were observed between the enlarged terminals and adjacent dendrites. Most of these synapses were asymmetric (Gray type I), although a few of them were symmetric (Gray type II). These data suggest that hypocretin transmission is altered during aging, which would be expected to result in age-related changes in the functioning of the hypocretinergic system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15619537     DOI: 10.1016/j.neulet.2003.08.085

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Sleep disorders, obesity, and aging: the role of orexin.

Authors:  Joshua P Nixon; Vijayakumar Mavanji; Tammy A Butterick; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Ageing Res Rev       Date:  2014-11-22       Impact factor: 10.895

2.  Frontal white matter integrity in adults with Down syndrome with and without dementia.

Authors:  David Powell; Allison Caban-Holt; Gregory Jicha; William Robertson; Roberta Davis; Brian T Gold; Frederick A Schmitt; Elizabeth Head
Journal:  Neurobiol Aging       Date:  2014-02-04       Impact factor: 4.673

Review 3.  Intranasal insulin and orexins to treat age-related cognitive decline.

Authors:  Jennifer M Erichsen; Coleman B Calva; Lawrence P Reagan; Jim R Fadel
Journal:  Physiol Behav       Date:  2021-02-21

4.  Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.

Authors:  Wenzheng Xia; Fengyun Zhang; Congying Xie; Miaomiao Jiang; Meng Hou
Journal:  Stem Cell Res Ther       Date:  2015-04-22       Impact factor: 6.832

5.  Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex.

Authors:  Leah Aluisio; Ian Fraser; Tamara Berdyyeva; Volha Tryputsen; Brock T Shireman; James Shoblock; Timothy Lovenberg; Christine Dugovic; Pascal Bonaventure
Journal:  Front Neurosci       Date:  2014-05-20       Impact factor: 4.677

Review 6.  The orexin neuropeptide system: physical activity and hypothalamic function throughout the aging process.

Authors:  Anastasia N Zink; Claudio Esteban Perez-Leighton; Catherine M Kotz
Journal:  Front Syst Neurosci       Date:  2014-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.